Oral Decitabine/Cedazuridine (DEC-C) in Combination With Nivolumab for Patients With Mucosal Melanoma

NCT05089370 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

8

Enrollment

OTHER

Sponsor class

Conditions

Malignant Melanoma

Interventions

COMBINATION_PRODUCT: Oral Decitabine/Cedazuridine (DEC-C) in Combination with Nivolumab

Sponsor

University of Colorado, Denver

Collaborators

[object Object]
[object Object]